W Bradley Bickham Sells 705 Shares of Addus Homecare Co. (ADUS) Stock
Addus Homecare Co. (NASDAQ:ADUS) insider W Bradley Bickham sold 705 shares of the business’s stock in a transaction that occurred on Thursday, January 17th. The shares were sold at an average price of $64.13, for a total value of $45,211.65. Following the sale, the insider now owns 21,010 shares in the company, valued at $1,347,371.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of NASDAQ:ADUS opened at $63.59 on Friday. Addus Homecare Co. has a fifty-two week low of $33.25 and a fifty-two week high of $77.82. The firm has a market capitalization of $832.90 million, a price-to-earnings ratio of 39.25, a P/E/G ratio of 1.86 and a beta of 0.02. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.37.
Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.08. Addus Homecare had a return on equity of 9.55% and a net margin of 3.25%. The firm had revenue of $137.63 million for the quarter, compared to analysts’ expectations of $139.43 million. As a group, research analysts predict that Addus Homecare Co. will post 1.68 EPS for the current fiscal year.
ADUS has been the topic of a number of research reports. Royal Bank of Canada initiated coverage on Addus Homecare in a research report on Monday, October 8th. They set an “outperform” rating and a $81.00 price objective on the stock. Zacks Investment Research upgraded Addus Homecare from a “strong sell” rating to a “hold” rating in a research report on Friday, November 9th. BidaskClub cut Addus Homecare from a “buy” rating to a “hold” rating in a research report on Saturday, September 22nd. Finally, Oppenheimer boosted their price objective on Addus Homecare from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, November 7th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $75.38.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Recommended Story: How to Use the New Google Finance Tool
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.